02.05.2013 - Sanofi is stepping up the development of a fixed combination of diabetes treatments Lantus and Lyxumia to sidestep an earlier setback with a similar pen device and take advantage...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)